Hsia Beau, Sure Asritha, Dongre Roshan, Jo Nicolas, Kuzniar Julia, Bitar Gabriel, Alshaka Saif A, Kim Jeeho D, Valencia-Sanchez Bastien A, Brandel Michael G, Sato Mariko, Crawford John Ross, Levy Michael L, Polster Sean P, Patel Vijay A
School of Medicine, Creighton University, Phoenix, AZ 85012, USA.
School of Medicine, Boston University, Boston, MA 02118, USA.
Cancers (Basel). 2025 May 1;17(9):1544. doi: 10.3390/cancers17091544.
Nasopharyngeal carcinoma (NPC) is a rare head and neck cancer arising from the mucosal lining of the nasopharynx, for which systemic therapeutic options remain scarce, reflecting the limited characterization of its genomic profile. This study utilized a large patient-level genomic repository to characterize genetic alterations, identify potential therapeutic targets, and improve disease modeling in NPC.
A retrospective analysis of NPC samples was conducted using the AACR Project GENIE database. Targeted sequencing data were analyzed for recurrent somatic mutations, tumor mutational burden, and chromosomal copy number variations, with significance set at < 0.05.
Frequent mutations were identified in (20%), (16%), (9.6%), (6.4%), and (5.6%), implicating the p53, NF-κB, and PI3K pathways in NPC development. Notably, significantly distinct mutational profiles were observed based on both sex and race, with female patients exhibiting higher frequencies of , , and mutations and non-Asian patients showing enrichment in , , and mutations.
This study presents a detailed genomic profile of NPC, identifying key mutations within established cancer-associated pathways. The identification of frequently mutated pathways (p53, NF-κB, and PI3K) suggests potential targets for novel therapies. Furthermore, distinct mutational landscapes in female and Asian NPC patients offer possibilities for precision therapeutic interventions.
鼻咽癌(NPC)是一种起源于鼻咽部黏膜的罕见头颈癌,其全身治疗选择仍然有限,这反映了其基因组特征的有限描述。本研究利用一个大型患者水平的基因组库来表征基因改变,识别潜在的治疗靶点,并改善鼻咽癌的疾病建模。
使用美国癌症研究协会(AACR)项目GENIE数据库对鼻咽癌样本进行回顾性分析。分析靶向测序数据中的复发性体细胞突变、肿瘤突变负担和染色体拷贝数变异,显著性设定为<0.05。
在(20%)、(16%)、(9.6%)、(6.4%)和(5.6%)中发现了频繁突变,这表明p53、NF-κB和PI3K信号通路在鼻咽癌发生中起作用。值得注意的是,基于性别和种族观察到显著不同的突变谱,女性患者中、和突变的频率较高,非亚洲患者中、和突变更为富集。
本研究展示了鼻咽癌详细的基因组特征,确定了既定癌症相关信号通路中的关键突变。频繁突变信号通路(p53、NF-κB和PI3K)的识别提示了新疗法的潜在靶点。此外,女性和亚洲鼻咽癌患者不同的突变格局为精准治疗干预提供了可能。